# Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL

> **NCT06175702** · — · NOT_YET_RECRUITING · sponsor: **PETHEMA Foundation** · enrollment: 150 (estimated)

## Conditions studied

- Lymphoblastic Leukemia
- Philadelphia-Positive ALL
- Adult ALL

## Interventions

- **DRUG:** Vincristine
- **DRUG:** Dexamethasone
- **DRUG:** Imatinib
- **DRUG:** Cytarabine
- **DRUG:** Mercaptopurine
- **DRUG:** Methotrexate
- **DRUG:** Ponatinib
- **PROCEDURE:** allogeneic stem cell transplantation
- **PROCEDURE:** Total body irradiation
- **DRUG:** Cyclophosphamide
- **DRUG:** Fludarabine

## Key facts

- **NCT ID:** NCT06175702
- **Lead sponsor:** PETHEMA Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-12-25
- **Primary completion:** 2028-12-25
- **Final completion:** 2030-12-25
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06175702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06175702, "Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06175702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*